Saturday, February 19, 2022 10:44:08 AM
So currently, NVAC is trading at $9.78 (I was close enough), but the Warrants are trading much higher (.19) and the Rights are trading much lower (.18).
I'm guessing that is because the Rights are "seen" to be much more risky than the Warrants, but as far as I am concerned, and based upon how I feel about the company and what the founders' ultimate goals and agenda are, I personally believe that the risk attributed to the Rights is exaggerated.
Therefore, I feel that the Rights are being traded at about half of where they should be.
I'll check back in another month or so, to see how my thinking pans out.
Godspeed
1142257
These opinions are my own and are not intended as investment advice. If you feel that my statements are "Pumping", Propaganda, or manipulative in any way, please refrain from trading and seek medical treatment immediately.
Recent NVAC News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/11/2024 01:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:32 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/28/2024 02:34:46 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/29/2024 01:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:00:10 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/16/2024 01:27:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:10:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/11/2023 11:10:15 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/01/2023 10:24:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:00:35 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:29:23 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/13/2023 09:16:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 09:16:05 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 09/12/2023 09:19:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:00:37 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 07/21/2023 08:07:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM